GLP-1 Weight Loss in Wilmington (2026)

Wilmington at a Glance

About GLP-1 Access in Wilmington

Wilmington is a major city in Delaware with a population of approximately 70,898 residents. Telehealth is legal in Delaware, and licensed GLP-1 providers can prescribe semaglutide or tirzepatide and ship directly to Wilmington ZIP codes. Prices, formulary availability, and specific provider state coverage vary — confirm with the provider before starting.

The greater Wilmington metro area is home to roughly 730,617 residents — one of the larger telehealth markets in Delaware, even though the city proper is smaller.

Delaware's adult obesity rate is approximately 35.7% based on CDC Behavioral Risk Factor Surveillance System data^[2], and state rankings are published in CDC's Adult Obesity Facts^[3]. Delaware ranks #17 of 50 states for adult obesity prevalence — near the national middle — and telehealth gives Wilmington residents a fast, private alternative to scheduling with a local obesity-medicine specialist. Before starting treatment, it's worth understanding what the clinical trials actually showed about GLP-1 side effects.

Delaware Medicaid does not currently cover GLP-1s for weight loss alone (Diabetes only), which is why cash-pay compounded semaglutide or tirzepatide — averaging $215/month — is the realistic path for most Wilmington residents seeking obesity treatment outside a type 2 diabetes diagnosis.

Looking beyond Wilmington? See all GLP-1 providers in Delaware, or read our Delaware Medicaid GLP-1 coverage & prior-authorization guide.

Browse by Medication

Browse all 341 providers with undisclosed coverage on the Delaware page →

In-Person vs Telehealth in Wilmington

Patients in Wilmington have two main paths to GLP-1 treatment: an in-person obesity medicine or bariatric program, or a licensed telehealth provider that ships to Delaware addresses. In-person programs are generally preferable for patients with complex medical needs, those pursuing bariatric surgery, or patients whose insurance covers a brand-name anti-obesity GLP-1 and requires in-person documentation. Telehealth is generally preferable for patients seeking cash-pay compounded semaglutide or tirzepatide from a 503A compounding pharmacy^[5]. Medicaid and commercial insurance coverage of anti-obesity GLP-1s in Delaware varies by plan^[4].

In-person weight-management clinics in Wilmington (34 in our directory)

From the NPI registry, cross-checked against obesity-medicine and bariatric taxonomy codes — mostly endocrinology, diabetes & metabolism, obesity medicine (preventive medicine).

• Amanda Mckenna — Endocrinology, Diabetes & Metabolism, 501 W 14th St FL 4
• Amy Wachter — Endocrinology, Diabetes & Metabolism, 1601 Kirkwood Hwy FL 6
• Christiana Care Health Services Inc — Endocrinology, Diabetes & Metabolism, 3506 Kennett Pike
• Christiana Care Health Services, Inc — Endocrinology, Diabetes & Metabolism, 3506 Kennett Pike
• Franklin Thelmo — Endocrinology, Diabetes & Metabolism, 501 W 14th St FL 4
• Jennifer Hall — Obesity Medicine (Preventive Medicine), 2417 Silverside Rd Ste 4
• Prakash Seshadri — Endocrinology, Diabetes & Metabolism, 3506 Kennett Pike
• Richard M Plotzker, M.D. — Endocrinology, Diabetes & Metabolism, 3411 Silverside Rd

Browse all 34 Wilmington clinics in the directory →

Cost of GLP-1 Medications in Wilmington

Brand-name Wegovy in Wilmington typically costs $1,349/month without insurance, while Zepbound runs $1,086/month. Compounded semaglutide through telehealth providers averages $215/month in Delaware, representing savings of more than $13,000 per year. For a full breakdown of every low-cost option, read our cheapest way to get GLP-1s without insurance guide. If you're deciding between the two paths, see our compounded vs. branded GLP-1 decision guide.

Frequently Asked Questions